Contributor:

David A. Eichenbaum, MD, Manish Nagpal, MS, DO, FRCS

PEDs in HARBOR

David Eichenbaum, MD

The EVA Modes for Retinectomy and Vitrectomy

Colin McCannel, MD, David Eichenbaum, MD

Innovations in Retina: Gene Therapy

I. Paul Singh, MD; and David Eichenbaum, MD

The Benefits of the TDC Cutter

Colin McCannel, MD, David Eichenbaum, MD

Keeping Patients at the Center of GA Therapy: Motivating Patients, Halting Treatment, and Monitoring Progression

John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH

Keeping Patients at the Center of GA Therapy: Older Caretaker for Whom Driving Is Paramount

John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH

Keeping Patients at the Center of GA Therapy: Older, Working Patient Motivated to Continue Treatment

John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH

Keeping Patients at the Center of GA Therapy: A Young Patient with GA and Good Vision

John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH

Fact or Fiction: Are Integrin Inhibitors a Viable Strategy?

Carl D. Regillo, MD, FACS, David A. Eichenbaum, MD, and Anat Loewenstein, MD, MHA

Fact or Fiction: Can a Topical Formulation Reach the Retina?

Carl D. Regillo, MD, FACS, David A. Eichenbaum, MD, and Anat Loewenstein, MD, MHA

Fact or Fiction: Will Compliance Be an Issue With a Topical Drop for DR?

Carl D. Regillo, MD, FACS, David A. Eichenbaum, MD, and Anat Loewenstein, MD, MHA

Complications Associated with PVR Surgery: New Approaches

David A. Eichenbaum, MD, Manish Nagpal, MS, DO, FRCS